Role of Clinical Pulmonary Infection Score and Sonopulmonary Infection Score in Diagnosis and Predicting Outcome of VAP in RUCU

October 11, 2024 updated by: Esraa khaled, Assiut University

-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively

The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the infection was mostly likely acquired:

community-acquired pneumonia (CAP), when a patient is in the hospital <48h before the pneumonia is suspected; hospital-acquired pneumonia (HAP), when a patient is in the hospital >48h before the pneumonia develops, but is not associated with mechanical ventilation; and ventilator-associated pneumonia (VAP), when a patient is mechanically ventilated and intubated for >48h before the pneumonia develops The causative pathogens in each scenario are different, and treatment strategies vary as a consequence.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively

The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the infection was mostly likely acquired:

community-acquired pneumonia (CAP), when a patient is in the hospital <48h before the pneumonia is suspected; hospital-acquired pneumonia (HAP), when a patient is in the hospital >48h before the pneumonia develops, but is not associated with mechanical ventilation; and ventilator-associated pneumonia (VAP), when a patient is mechanically ventilated and intubated for >48h before the pneumonia develops The causative pathogens in each scenario are different, and treatment strategies vary as a consequence.

Study Type

Observational

Enrollment (Estimated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Esraa Khaled Abo hossiba, Resident doctor
  • Phone Number: 01126914592
  • Email: ee297700@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients with VAP Patients who don't develop VAP

Description

Inclusion Criteria:

  • Patient 18 yrs or more Mechanically ventilated patients after 48 hrs after admission of ICU

Exclusion Criteria:

  • Patient less than 18 yrs Patients diagnosed as pneumonia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients
Time Frame: 4 years
Diagnosis of VAP in RICU Patients
4 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients
Time Frame: 4 years
Diagnosis of VAP in RICU PATIENTS
4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2024

Primary Completion (Estimated)

September 19, 2025

Study Completion (Estimated)

December 30, 2027

Study Registration Dates

First Submitted

October 11, 2024

First Submitted That Met QC Criteria

October 11, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

October 15, 2024

Last Update Submitted That Met QC Criteria

October 11, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Assiit University

Drug and device information, study documents

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients with VAP in RICU Patients

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe